Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo …
MM van Dijk, R Vissenberg, E Fliers… - The lancet Diabetes & …, 2022 - thelancet.com
Background Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher risk
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo …
MM van Dijk, R Vissenberg, E Fliers… - The Lancet Diabetes …, 2022 - research.regionh.dk
BACKGROUND: Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher
risk of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
risk of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
[PDF][PDF] Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind …
MM van Dijk, R Vissenberg, E Fliers, JAM van der Post… - 2022 - researchgate.net
Background Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher risk
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo …
MM van Dijk, R Vissenberg, E Fliers… - Lancet Diabetes & …, 2022 - research.rug.nl
Background Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher risk
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo …
MM van Dijk, R Vissenberg… - Lancet …, 2022 - researchinformation.amsterdamumc …
BACKGROUND: Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher
risk of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
risk of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
[HTML][HTML] Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind …
MM van Dijk, R Vissenberg, E Fliers… - Lancet Diabetes & …, 2022 - researchportal.vub.be
BACKGROUND: Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher
risk of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
risk of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo …
MM van Dijk, R Vissenberg, E Fliers… - The Lancet Diabetes & …, 2022 - vbn.aau.dk
BACKGROUND: Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher
risk of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
risk of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
[PDF][PDF] Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind …
MM van Dijk, R Vissenberg, E Fliers… - 2022 - scholarlypublications …
Background Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher risk
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo …
MM van Dijk, R Vissenberg, E Fliers… - … lancet. Diabetes & …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher risk
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo …
MM van Dijk, R Vissenberg, E Fliers… - The Lancet Diabetes & …, 2022 - Elsevier
Background Women positive for thyroid peroxidase antibodies (TPO-Ab) have a higher risk
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …
of recurrent pregnancy loss. Evidence on whether levothyroxine treatment improves …